Press Releases on December 6, 2024 - EIN Presswire - Press Release Distribution Service

Published on December 6, 2024 - 21:03 GMT

NurExone Announces Promising Preclinical Results in Restoring Vision After Optic Nerve Damage

TORONTO and HAIFA, Israel, Dec. 06, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) ("NurExone" or the "Company"), a biopharmaceutical company developing exosome-based regenerative therapies, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on December 6, 2024 - 21:01 GMT

Monroe Capital Corporation Announces Fourth Quarter Distribution of $0.25 Per Share

CHICAGO, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Monroe Capital Corporation (the “Company”) (NASDAQ: MRCC) announced today that its Board of Directors has declared a distribution of $0.25 per share for the fourth quarter of 2024, payable on December 30, 2024 to …

Distribution channels: Banking, Finance & Investment Industry ...

Published on December 6, 2024 - 21:01 GMT

Mulvihill Enhanced Split Preferred Share ETF Declares Monthly Distribution

TORONTO, Dec. 06, 2024 (GLOBE NEWSWIRE) -- (TSX: SPFD) Mulvihill Enhanced Split Preferred Share ETF has declared a monthly cash distribution in the amount of $0.08333 per unit, payable on January 8, 2025 to unitholders of record on December 31, 2024. For …

Distribution channels: Banking, Finance & Investment Industry ...

Published on December 6, 2024 - 21:01 GMT

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

DURHAM, N.C., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on December 2, 2024, the Compensation Committee of Chimerix’s Board of Directors granted inducement awards to three new employees of non-statutory stock options to …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on December 6, 2024 - 21:01 GMT

Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024

– OLE data shows sustained monthly reduction in seizure frequency, impressive seizure freedom rates, and consistent AE safety profile suggesting long-term efficacy and tolerability of azetukalner – Approximately one in three patients on drug for at least …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on December 6, 2024 - 21:01 GMT

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NAARDEN, The Netherlands and MIAMI, Dec. 06, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on December 6, 2024 - 21:01 GMT

DT Midstream Announces Closing of Offering of Senior Secured Notes

DETROIT, Dec. 06, 2024 (GLOBE NEWSWIRE) -- DT Midstream, Inc. (“DT Midstream” or the “Company”) (NYSE: DTM) today announced that it has closed the previously announced offering (the “Offering”) of $650,000,000 of 5.800% Senior Secured Notes due 2034 (the “ …

Distribution channels: Shipping, Storage & Logistics ...

Published on December 6, 2024 - 21:01 GMT

Frequency Electronics Announces Second Quarter Fiscal 2025 Financial Results Conference Call: Tuesday, December 10, 2024, at 4:30 ...

MITCHEL FIELD, N.Y., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Frequency Electronics, Inc. (NASDAQ: FEIM), will hold a conference call to discuss results for the second quarter of its fiscal year 2025, ended October 31, 2024, on Tuesday, December 10, 2024, at 4:30 …

Distribution channels: